PTH1R and osteoporosis: The present study aimed to analyze (1) alveolar bone healing following maxillary tooth extraction, implant osseointegration, and peri-implant regeneration in a rat model of postmenopausal osteoporosis and (2) to investigate the effects of ABL, a PTHR1 agonist that is FDA-approved for the treatment of osteoporosis, on alveolar bone regeneration.